PL1807101T3 - Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły - Google Patents

Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły

Info

Publication number: PL1807101T3
Authority: PL; Poland
Prior art keywords: methods; devices; biological molecules; continuous manufacturing; integrated continuous
Prior art date: 2004-09-30

Application number

PL05800224.7T

Other languages

English (en)

Inventor

Jens Vogel

Roberto Giovannini

Konstantin B. Konstantinov

Huong Nguyen

Peng Wu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-30

Filing date

2005-09-30

Publication date

2016-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36143124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1807101(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-30 Application filed filed Critical

2016-11-30 Publication of PL1807101T3 publication Critical patent/PL1807101T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/24—Apparatus for enzymology or microbiology tube or bottle type
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/14—Pressure control
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/16—Flow or flux control
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/10—Specific supply elements
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/10—Specific supply elements
- B01D2313/105—Supply manifolds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/18—Specific valves
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2317/00—Membrane module arrangements within a plant or an apparatus
- B01D2317/04—Elements in parallel

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Water Supply & Treatment (AREA)
Analytical Chemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Sustainable Development (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Separation Using Semi-Permeable Membranes (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Filtration Of Liquid (AREA)
Apparatus For Disinfection Or Sterilisation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL05800224.7T 2004-09-30 2005-09-30 Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły PL1807101T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US61499504P	2004-09-30	2004-09-30

Publications (1)

Publication Number	Publication Date
PL1807101T3 true PL1807101T3 (pl)	2016-11-30

Family

ID=36143124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05800224.7T PL1807101T3 (pl)	2004-09-30	2005-09-30	Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły

Country Status (25)

Country	Link
US (3)	US9045725B2 (pl)
EP (2)	EP1807101B1 (pl)
JP (2)	JP5579966B2 (pl)
KR (2)	KR101238798B1 (pl)
CN (2)	CN101076347B (pl)
AU (1)	AU2005292358B2 (pl)
BR (1)	BRPI0515849B1 (pl)
CA (1)	CA2579845C (pl)
CY (1)	CY1117699T1 (pl)
DK (2)	DK2550971T3 (pl)
ES (2)	ES2570006T3 (pl)
HK (1)	HK1110519A1 (pl)
HR (1)	HRP20070097B1 (pl)
HU (2)	HUE027136T2 (pl)
IL (5)	IL181775A (pl)
LT (1)	LT2550971T (pl)
NO (2)	NO341439B1 (pl)
NZ (2)	NZ588616A (pl)
PL (1)	PL1807101T3 (pl)
PT (1)	PT2550971T (pl)
RU (1)	RU2390526C2 (pl)
SI (1)	SI2550971T1 (pl)
UA (3)	UA112529C2 (pl)
WO (1)	WO2006039588A2 (pl)
ZA (1)	ZA200702578B (pl)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1807101B1 (en)	2004-09-30	2016-04-13	Bayer Healthcare LLC	Devices and methods for integrated continuous manufacturing of biological molecules
MX345141B (es)	2006-09-13	2017-01-18	Abbvie Inc *	Mejoras de cultivos celulares.
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
FR2920429B1 (fr) *	2007-08-30	2012-10-05	Lfb Biotechnologies	Procede de purification du facteur viii et du facteur von willebrand
CN102257005A (zh)	2008-10-20	2011-11-23	雅培制药有限公司	在抗体纯化过程中的病毒灭活
WO2010141039A1 (en)	2008-10-20	2010-12-09	Abbott Laboratories	Isolation and purification of antibodies using protein a affinity chromatography
US9527010B2 (en)	2009-09-25	2016-12-27	Ge Healthcare Bio-Sciences Corp.	Separation system and method
JP5860887B2 (ja) *	2010-10-15	2016-02-16	ジーイー・ヘルスケア・バイオサイエンス・コーポレイション	大容量使い捨て限外濾過システム及び方法
CN102154408B (zh) *	2011-01-13	2013-06-05	天津市工业微生物研究所	小核菌硬葡聚糖在线发酵提取方法及系统
US10774304B2 (en) *	2011-03-08	2020-09-15	University Of Maryland, Baltimore County	System and method for production of on-demand proteins in a portable unit for point of care delivery
US9388373B2 (en) *	2011-03-08	2016-07-12	University Of Maryland Baltimore County	Microscale bioprocessing system and method for protein manufacturing
US9982227B2 (en)	2011-03-08	2018-05-29	University Of Maryland, Baltimore County	System and method for production of on-demand proteins in a portable unit for point of care delivery
US12227734B2 (en)	2011-03-08	2025-02-18	University Of Maryland, Baltimore County	Microscale bioprocessing system and method for protein manufacturing from human blood
EP2702077A2 (en)	2011-04-27	2014-03-05	AbbVie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN104025408A (zh) *	2011-10-11	2014-09-03	森春减压系统有限公司	用于电力变压器的减压系统
CN104160013B (zh)	2012-01-18	2017-07-28	拜尔健康护理有限责任公司	灌流式生物反应器系统及操作其的方法
US9997264B2 (en) *	2012-02-14	2018-06-12	Control Components, Inc.	Enhanced nuclear sump strainer system
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
US9181572B2 (en)	2012-04-20	2015-11-10	Abbvie, Inc.	Methods to modulate lysine variant distribution
WO2013176754A1 (en)	2012-05-24	2013-11-28	Abbvie Inc.	Novel purification of antibodies using hydrophobic interaction chromatography
EP2682168A1 (en)	2012-07-02	2014-01-08	Millipore Corporation	Purification of biological molecules
CA2883272A1 (en)	2012-09-02	2014-03-06	Abbvie Inc.	Methods to control protein heterogeneity
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
EP2958988A2 (en)	2013-02-22	2015-12-30	Genzyme Corporation	Microcarrier perfusion culturing methods and uses thereof
EP2958989B1 (en)	2013-02-22	2018-12-26	Genzyme Corporation	Microcarrier perfusion culturing methods and uses thereof
RU2768003C2 (ru) *	2013-03-08	2022-03-22	Джензим Корпорейшн	Интегрированное непрерывное производство терапевтических белковых лекарственных веществ
WO2014143205A1 (en)	2013-03-12	2014-09-18	Abbvie Inc.	Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en)	2013-03-14	2016-11-22	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
WO2014159579A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
EP3052640A2 (en)	2013-10-04	2016-08-10	AbbVie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
TWI709570B (zh)	2014-01-17	2020-11-11	美商健臻公司	無菌層析法及製法
TWI709569B (zh)	2014-01-17	2020-11-11	美商健臻公司	無菌層析樹脂及其用於製造方法的用途
EP3137484A1 (en) *	2014-05-02	2017-03-08	Novo Nordisk A/S	Integrated continuous biomanufacturing process
KR102370714B1 (ko)	2014-05-13	2022-03-03	암겐 인코포레이티드	필터 및 여과 공정과 함께 사용하기 위한 공정 제어 시스템 및 방법
CA2946425C (en) *	2014-05-27	2022-08-30	Artificial Cell Technologies, Inc.	Automated layer by layer construction of multilayer coated cores by tff
TW202204596A (zh)	2014-06-06	2022-02-01	美商健臻公司	灌注培養方法及其用途
TWI776235B (zh)	2014-06-09	2022-09-01	美商健臻公司	種子罐培養法(seed train processes)及其用途
WO2015195453A2 (en)	2014-06-16	2015-12-23	Emd Millipore Corporation	Methods for increasing the capacity of flow-through processes
WO2015195452A2 (en)	2014-06-16	2015-12-23	Emd Millipore Corporation	Single-pass filtration systems and processes
CN106132517B (zh)	2014-06-25	2019-12-13	Emd 密理博公司	过滤器元件、切向流过滤系统、液体过滤工艺
WO2016033553A1 (en)	2014-08-29	2016-03-03	Emd Millipore Corporation	Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
WO2016033546A1 (en)	2014-08-29	2016-03-03	Emd Millipore Corporation	Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
USD761381S1 (en)	2014-12-18	2016-07-12	Emd Millipore Corporation	Retentate plate
USD762811S1 (en)	2014-12-18	2016-08-02	Emd Millipore Corporation	Diverter plate
EP3093335A1 (de)	2015-05-13	2016-11-16	Bayer Technology Services GmbH	Prozessleitsystem zur regelung und steuerung einer modular aufgebauten anlage zur produktion von biopharmazeutischen und biologischen makromolekularen produkten
ITUA20161506A1 (it) *	2016-03-09	2017-09-09	Della Toffola Spa	Metodo ed impianto perfezionato di filtrazione tangenziale
WO2017160739A1 (en)	2016-03-14	2017-09-21	Pendo TECH	Processing system for multiple tangential flow filtration stations in bioprocessing applications
JP6722772B2 (ja)	2016-06-09	2020-07-15	イーエムディーミリポアコーポレーション	放射状経路のフィルターエレメント、それを使用するシステムおよび方法
WO2018017022A1 (en) *	2016-07-21	2018-01-25	Agency For Science, Technology And Research	Apparatus for outer wall focusing for high volume fraction particle microfiltration and method for manufacture thereof
WO2018086997A1 (en) *	2016-11-11	2018-05-17	Bayer Pharma Aktiengesellschaft	Method for sampling fluid streams for monitoring contaminants in a continuous flow
EP3141594A3 (en) *	2016-11-11	2017-06-14	Bayer Pharma Aktiengesellschaft	Method for sampling fluid streams for monitoring contaminants in a continuous flow
WO2018107099A1 (en) *	2016-12-09	2018-06-14	Lonza Ltd	Method for the reduction of viral titer in pharmaceuticals
EP3354330A1 (en) *	2017-01-25	2018-08-01	Sartorius Stedim Biotech GmbH	Automated modular filtration system
CA2994643A1 (en) *	2017-02-14	2018-08-14	Bart Lipkens	Bioreactor using acoustic standing waves
WO2018159847A1 (ja) *	2017-03-03	2018-09-07	富士フイルム株式会社	細胞培養装置及び細胞培養方法
JP2018153168A (ja) *	2017-03-21	2018-10-04	国立大学法人九州大学	微生物収集装置
DE102017110482A1 (de) *	2017-05-15	2018-11-15	Sartorius Stedim Biotech Gmbh	Filtrationsmodul bzw. Reinigungsmodul für modulares Filtrationssystem
DE102017111133A1 (de) *	2017-05-22	2018-11-22	Sartorius Stedim Biotech Gmbh	Vorkonfigurierte Einweg-Filtrationsvorrichtung
TWI675696B (zh) *	2017-06-01	2019-11-01	美商Ｅｍｄ密理博公司	用於灌注應用之切向流過濾裝置
JP6751818B2 (ja)	2017-06-20	2020-09-09	旭化成株式会社	中空糸膜モジュールおよびろ過方法
TWI846694B (zh) *	2018-05-04	2024-07-01	美商健臻公司	具有過濾系統的灌注式生物反應器
US12071607B2 (en) *	2018-06-01	2024-08-27	Lonza Ltd.	Midscale model for organic growth and phasing
GB201810772D0 (en) *	2018-06-29	2018-08-15	Ge Healthcare Bio Sciences Ab	Method in bioprocess purification system
MX2021002314A (es)	2018-08-31	2021-04-28	Genzyme Corp	Resina de cromatografia esteril y uso de la misma en procedimientos de produccion.
GB201816871D0 (en)	2018-10-17	2018-11-28	Ge Healthcare Bio Sciences Ab	A bioprocessing fluid sensor arrangement
DE102019100209A1 (de)	2019-01-07	2020-07-09	Sartorius Stedim Biotech Gmbh	Vorrichtung und Verfahren zum Ausgleich von kurzfristigen Druck- oder Volumenschwankungen eines Mediums in einem kontinuierlich geführten biopharmazeutischen Prozess
KR20210127947A (ko) *	2019-02-15	2021-10-25	저스트-에보텍 바이오로직스, 아이엔씨.	자동화된 바이오 제조 시스템, 설비 및 공정
CN111018968B (zh) *	2019-12-16	2021-07-27	兴盟生物医药(苏州)有限公司	一种通过超滤浓缩制备高浓度抗体制剂的方法
EP4036672B1 (en)	2021-01-29	2024-03-06	Tata Consultancy Services Limited	Method to control a continuous bioprocessing
GB202109015D0 (en) *	2021-06-23	2021-08-04	Puridify Ltd	A method for purifying a feed in a chromatography system
JPWO2023191008A1 (pl) *	2022-03-30	2023-10-05
US12157873B2 (en) *	2022-09-28	2024-12-03	Genzyme Corporation	Systems and devices for producing biological products and methods of using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5157113A (en) *	1987-08-10	1992-10-20	Miles Inc.	Removal of nucleic acids from monoclonal antibody preparations
US5256294A (en) *	1990-09-17	1993-10-26	Genentech, Inc.	Tangential flow filtration process and apparatus
US5463029A (en) *	1992-11-23	1995-10-31	Immunex Corporation	Purification of fusion proteins comprising GM-CSF and IL-3
DK0757717T3 (da)	1994-05-16	2006-09-25	Merck & Co Inc	Papillomavirusvacciner
US5616595A (en)	1995-06-07	1997-04-01	Abbott Laboratories	Process for recovering water insoluble compounds from a fermentation broth
JP3566461B2 (ja)	1996-06-28	2004-09-15	ユニ・チャーム株式会社	使い捨ての体液吸収性物品
US7122344B2 (en) *	1997-05-28	2006-10-17	Claragen, Inc.	Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
IT1302026B1 (it) *	1997-08-22	2000-07-20	Hoffmann La Roche	Materiali immunologici e metodi per la rivelazione di diidropirimidinadeidrogenasi.
US6022477A (en) *	1997-11-14	2000-02-08	New Jersey Institute Of Technology	Method and apparatus for isolation purification of biomolecules
US7820796B2 (en)	1998-03-12	2010-10-26	Genetics Institute, Llc.	Methods for producing Factor VIII proteins
US6444223B1 (en) *	1999-05-28	2002-09-03	Alkermes Controlled Therapeutics, Inc.	Method of producing submicron particles of a labile agent and use thereof
US6544424B1 (en) *	1999-12-03	2003-04-08	Refined Technology Company	Fluid filtration system
US6350382B1 (en) *	2000-06-23	2002-02-26	Scilog, Inc.	Enhancing filtration yields in tangential flow filtration
WO2003004690A2 (en) *	2001-07-06	2003-01-16	454$m(3) CORPORATION	Method for isolation of independent, parallel chemical micro-reactions using a porous filter
CA2458980C (en) *	2001-08-31	2012-10-30	Bayer Healthcare Ag	A unit and a process for carrying out high cell density fermentation
US6875459B2 (en) *	2001-09-10	2005-04-05	Henry B. Kopf	Method and apparatus for separation of milk, colostrum, and whey
US7078507B2 (en) *	2001-11-09	2006-07-18	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Synthetic genes for malarial proteins and methods of use
US20060172376A1 (en) *	2003-02-11	2006-08-03	Hassan Chadjaa	Method and device for the continuous production of biomolecules
RU2005129745A (ru)	2003-02-24	2006-03-20	Джитиси Байотерапьютикс, Инк. (Us)	Способы и устройство проточной фильтрации вдоль потока
US20050197496A1 (en)	2004-03-04	2005-09-08	Gtc Biotherapeutics, Inc.	Methods of protein fractionation using high performance tangential flow filtration
EP1807101B1 (en)	2004-09-30	2016-04-13	Bayer Healthcare LLC	Devices and methods for integrated continuous manufacturing of biological molecules

2005
- 2005-09-30 EP EP05800224.7A patent/EP1807101B1/en active Active
- 2005-09-30 CA CA2579845A patent/CA2579845C/en active Active
- 2005-09-30 DK DK12179336.8T patent/DK2550971T3/en active
- 2005-09-30 RU RU2007115901/13A patent/RU2390526C2/ru active
- 2005-09-30 LT LTEP12179336.8T patent/LT2550971T/lt unknown
- 2005-09-30 HU HUE05800224A patent/HUE027136T2/en unknown
- 2005-09-30 WO PCT/US2005/035364 patent/WO2006039588A2/en active Application Filing
- 2005-09-30 PL PL05800224.7T patent/PL1807101T3/pl unknown
- 2005-09-30 US US11/576,097 patent/US9045725B2/en active Active
- 2005-09-30 UA UAA201304498A patent/UA112529C2/uk unknown
- 2005-09-30 CN CN2005800331770A patent/CN101076347B/zh active Active
- 2005-09-30 ES ES05800224.7T patent/ES2570006T3/es active Active
- 2005-09-30 CN CN201210289781.1A patent/CN102794109B/zh active Active
- 2005-09-30 PT PT121793368T patent/PT2550971T/pt unknown
- 2005-09-30 HU HUE12179336A patent/HUE032538T2/en unknown
- 2005-09-30 JP JP2007534832A patent/JP5579966B2/ja active Active
- 2005-09-30 DK DK05800224.7T patent/DK1807101T3/en active
- 2005-09-30 EP EP12179336.8A patent/EP2550971B1/en active Active
- 2005-09-30 AU AU2005292358A patent/AU2005292358B2/en not_active Ceased
- 2005-09-30 ES ES12179336.8T patent/ES2634323T3/es active Active
- 2005-09-30 UA UAA200704547A patent/UA99249C2/ru unknown
- 2005-09-30 NZ NZ588616A patent/NZ588616A/en unknown
- 2005-09-30 KR KR1020077008684A patent/KR101238798B1/ko active Active
- 2005-09-30 SI SI200532141T patent/SI2550971T1/sl unknown
- 2005-09-30 BR BRPI0515849-4A patent/BRPI0515849B1/pt active IP Right Grant
- 2005-09-30 KR KR1020127030406A patent/KR101335936B1/ko active Active
- 2005-09-30 UA UAA201202077A patent/UA107937C2/ru unknown
- 2005-09-30 NZ NZ554307A patent/NZ554307A/en unknown
2007
- 2007-03-07 IL IL181775A patent/IL181775A/en active IP Right Grant
- 2007-03-12 HR HRP20070097AA patent/HRP20070097B1/hr active IP Right Grant
- 2007-03-28 ZA ZA2007/02578A patent/ZA200702578B/en unknown
- 2007-04-26 NO NO20072174A patent/NO341439B1/no unknown
2008
- 2008-05-02 HK HK08104831.7A patent/HK1110519A1/xx unknown
2010
- 2010-04-21 IL IL205228A patent/IL205228A/en active IP Right Grant
2011
- 2011-12-22 IL IL217157A patent/IL217157A/en active IP Right Grant
- 2011-12-22 IL IL217158A patent/IL217158A/en active IP Right Grant
- 2011-12-22 IL IL217159A patent/IL217159A/en active IP Right Grant
2012
- 2012-06-07 JP JP2012129422A patent/JP5762360B2/ja active Active
2013
- 2013-03-12 US US13/795,298 patent/US9133433B2/en active Active
- 2013-03-12 US US13/795,346 patent/US20130345402A1/en not_active Abandoned
2016
- 2016-05-11 CY CY20161100396T patent/CY1117699T1/el unknown
2017
- 2017-07-10 NO NO20171138A patent/NO341885B1/no unknown

Also Published As

Publication number	Publication date
EP1807101A2 (en)	2007-07-18
ZA200702578B (en)	2008-03-26
JP5762360B2 (ja)	2015-08-12
US9133433B2 (en)	2015-09-15
ES2634323T3 (es)	2017-09-27
HUE032538T2 (en)	2017-10-30
KR101335936B1 (ko)	2013-12-03
EP1807101A4 (en)	2010-03-24
HRP20070097A2 (en)	2008-11-30
BRPI0515849A (pt)	2008-08-12
EP1807101B1 (en)	2016-04-13
NZ588616A (en)	2012-05-25
NO341439B1 (no)	2017-11-13
DK2550971T3 (en)	2017-10-30
DK1807101T3 (en)	2016-05-23
US20080269468A1 (en)	2008-10-30
JP5579966B2 (ja)	2014-08-27
CN102794109A (zh)	2012-11-28
IL217158A (en)	2016-06-30
JP2008514237A (ja)	2008-05-08
IL205228A0 (en)	2011-07-31
US9045725B2 (en)	2015-06-02
IL217159A (en)	2015-04-30
PT2550971T (pt)	2017-10-02
RU2007115901A (ru)	2008-11-10
NO341885B1 (no)	2018-02-12
BRPI0515849B1 (pt)	2019-07-30
AU2005292358B2 (en)	2011-06-16
NO20171138A1 (no)	2007-06-27
IL217158A0 (en)	2012-01-31
EP2550971B1 (en)	2016-11-09
RU2390526C2 (ru)	2010-05-27
AU2005292358A1 (en)	2006-04-13
KR20070092949A (ko)	2007-09-14
UA112529C2 (uk)	2016-09-26
HK1110519A1 (en)	2008-07-18
IL217157A0 (en)	2012-01-31
US20130344585A1 (en)	2013-12-26
IL181775A (en)	2012-02-29
NZ554307A (en)	2011-06-30
WO2006039588A3 (en)	2007-05-18
IL217157A (en)	2015-04-30
UA107937C2 (en)	2015-03-10
US20130345402A1 (en)	2013-12-26
HUE027136T2 (en)	2016-08-29
SI2550971T1 (sl)	2017-08-31
EP2550971A1 (en)	2013-01-30
ES2570006T3 (es)	2016-05-13
CY1117699T1 (el)	2017-05-17
LT2550971T (lt)	2018-10-25
HRP20070097B1 (hr)	2018-03-23
CA2579845A1 (en)	2006-04-13
JP2012213772A (ja)	2012-11-08
KR20130003025A (ko)	2013-01-08
IL217159A0 (en)	2012-01-31
UA99249C2 (ru)	2012-08-10
IL205228A (en)	2015-09-24
CA2579845C (en)	2014-11-18
IL181775A0 (en)	2007-07-04
KR101238798B1 (ko)	2013-03-04
WO2006039588A2 (en)	2006-04-13
NO20072174L (no)	2007-06-27
CN101076347A (zh)	2007-11-21
CN101076347B (zh)	2012-09-26
CN102794109B (zh)	2015-10-07

Publication	Publication Date	Title
IL217157A0 (en)	2012-01-31	Devices and methods for integrated continuous manufacturing of biological molecules
IL188078A0 (en)	2008-03-20	Nano-ionic liquids and methods of use
IL179227A0 (en)	2007-03-08	Methods and reagents for the treatment of immunoinflammatory disorders
IL180251A0 (en)	2007-09-20	Methods and reagents for the treatment of metabolic disorders
IL213843A0 (en)	2011-07-31	4-aminotetracyclines and methods of use thereof
ZA200702069B (en)	2008-08-27	Silver-releasing articles and methods of manufacture
HK1108913A1 (en)	2008-05-23	Method and device for the treatment of biological samples
EP1718602A4 (en)	2007-12-12	THERAPEUTIC AND CARRIER MOLECULES
GB0508889D0 (en)	2005-06-08	Diamond transistor and method of manufacture thereof
EP1958650A4 (en)	2012-05-30	MEDICAL DEVICE AND METHOD OF MODIFYING THE SURFACE OF THE MEDICAL DEVICE
IL178593A (en)	2016-04-21	Specific antibodies of fcγriib and methods for their use
EP1933880A4 (en)	2009-11-18	OLIGORIBONUCLEOTIDES AND METHODS OF USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
GB0511976D0 (en)	2005-07-20	Methods and apparatus for the manufacture of microstructures
IL178996A0 (en)	2007-03-08	Thienopyridinone compounds and methods of treatment
IL182436A0 (en)	2007-07-24	Thienopyridinone compounds and methods of treatment
IL185309A0 (en)	2008-02-09	Isoqunoline compounds and methods of use thereof
HK1119096A1 (en)	2009-02-27	Blood filter device and method of manufacturing the same
GB0421164D0 (en)	2004-10-27	Medical devices and methods of making medical devices
EP1771902A4 (en)	2009-09-16	MICROSTRUCTURES AND METHODS OF MAKING
ZA200709024B (en)	2009-08-26	Method of well treatment and construction
EP1815226A4 (en)	2008-03-19	DEVICE AND METHOD FOR PURIFYING BIOLOGICAL SUBSTANCES
GB0400394D0 (en)	2004-02-11	Biosensor and method of manufacture
EP1812451A4 (en)	2009-10-21	COMPOUNDS AND METHODS OF USE THEREOF
GB0514728D0 (en)	2005-08-24	Biosensor and method of manufacture
GB0423963D0 (en)	2004-12-01	Microstructures and methods of manufacturing the same